Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis.

Full Abstract

PURPOSE: To investigate the long-term effect of oral acyclovir administered during the first 6 months after penetrating keratoplasty (PK) for herpetic eye disease (HED). METHODS: A 5-year follow-up was undertaken for a patient population from a placebo-controlled, randomized trial on acyclovir prophylaxis after keratoplasty. In this former study the effectiveness of oral acyclovir prophylaxis was significant during the first 2 years after keratoplasty. Prospective data such as graft survival, graft clarity, vascularization, infective events, and rejection episodes were obtained from the national keratoplasty follow-up registry. Additional clinical data were derived from the medical charts. RESULTS: For 47 of the original 63 enrolled patients, the 5-year follow-up was completed. Comparing the acyclovir group with the placebo group, we found that with regard to the cumulative clinically evident recurrences, there was a statistically significant lower monthly event rate in the acyclovir group (P = 0.037). There were no statistically significant differences in visual acuity or in the use of oral aciclovir between the two treatment groups. The incidences of graft failure, vascularization, and medication or surgery for glaucoma were too low to analyze differences between the two groups. CONCLUSION: The results of our study suggest that oral acyclovir prescribed during the first 6 months after PK for HED protects against clinically evident HED recurrences during the first 5 years following PK.

Author information

Author/s: Jansen, Aateke F G (AF); Rijneveld, Wilhelmina J (WJ); Remeijer, Lies (L); Völker-Dieben, Henny J M (HJ); Eggink, Catharina A (CA); Geerards, Annette J M (AJ); Mulder, Paul G H (PG); van Rooij, Jeroen (J);

Affiliation: Rotterdam Eye Hospital, Rotterdam, The Netherlands.

Journal and publication information

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

Journal: Cornea (Cornea), published in United States. (Language: eng)

Reference: 2009-Sep; vol 28 (issue 8) : pp 843-5

Dates: Created 2009/08/25; Completed 2009/10/29;

PMID: 19654536, status: MEDLINE (last retrieved date: 10/29/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.